Glucagon-Like Peptide-1 Receptor Agonist Switching and Treatment Persistence in Adults Without Diabetes

Key Points

• This research aims to evaluate how adults with obesity switch between GLP-1 receptor agonists and their adherence to treatment over 12 months.
• Conducted a cohort study
• Focused on adults with overweight or obesity
• Monitored GLP-1 receptor agonist switching patterns
• Assessed treatment persistence and adherence over 12 months
• Identified specific patterns in GLP-1 receptor agonist switching
• Measured treatment persistence after 12 months
• Evaluated adherence levels among participants